AMA Urges FDA To Hold Manufacturers Liable For GenAI Device Safety ow.ly/yss9106GRuf
AAHomeCare Rallies Behind Bill To Delay Some Competitive Bidding, Lobbies WH ow.ly/actm106GRue
FDA Finalizes NDI Guidance, Leaves Ingredient Eligibility Questions Unresolved ow.ly/ZRY2106GRuc
Dems Warn OBBBA Will Increase Oncology, Immunotherapy Spending ow.ly/jb2S106GRqA
Dems Warn OBBBA Will Increase Oncology, Immunotherapy Spending ow.ly/V8Ar106GRqz
Utah’s AI Policy Office Says Evaluator Network Is Expanding, Provides Evaluation Criteria ow.ly/pk3U106GRqy
Former GOP Lawmakers Warn Administration’s Vaccine Misinfo May Hurt Party In Midterms ow.ly/BnqV106GRmX
NABP: Retatrutide Death Reports Expose Gaps In Policing Black Market Peptide Sellers ow.ly/tAXM106GRju
NABP: Retatrutide Death Reports Expose Gaps In Policing Black Market Peptide Sellers ow.ly/6kTS106GR9p
SCOTUS Pushed To Again Consider Religious Exemptions To Vaccine Mandates ow.ly/lQaY106GR9h
Trump Women’s Health EO Creates New NIH Division, Task Force ow.ly/mTSe106GQ40
CMS Proposes $0 Generic Drug Copay, Reduced PBM Compensation In Rule To Implement CAA ow.ly/rFbo106GHh0
CMS Proposes New Protections For MA Patients Using Inaccurate Provider Directories ow.ly/Gbmg106GHgX
CMS Proposes $0 Generic Drug Copay, Reduced PBM Compensation In Rule To Implement CAA ow.ly/chkq106GHgV
Treasury, IRS Draft Rule Limits Access To PTCs ow.ly/zXzW106GHgU
Rare Disease Group To FDA: Align PDUFA With Drug Development Framework ow.ly/LXcV106GH7F
Rare Disease Group To FDA: Align PDUFA With Drug Development Framework ow.ly/OnjQ106GH7E
Dexcom Attempts To Address Social Media Fallout On New Mandatory Terms And Conditions ow.ly/OZLA106GH7C
New White House ‘SI Force’ Includes HHS’ Klomp, Holds Inaugural Meeting ow.ly/8vt2106GH7B
